Literature DB >> 17188255

Protecting endothelial function: A novel therapeutic target of ATP-sensitive potassium channel openers.

Tetsuo Minamino, Masatsugu Hori.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17188255     DOI: 10.1016/j.cardiores.2006.11.014

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  6 in total

1.  Chemerin/ChemR23 signaling axis is involved in the endothelial protection by K(ATP) channel opener iptakalim.

Authors:  Rui-jun Zhao; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2011-04-25       Impact factor: 6.150

2.  A new antihypertensive drug ameliorate insulin resistance.

Authors:  Yan-xia Liu
Journal:  Acta Pharmacol Sin       Date:  2012-04       Impact factor: 6.150

3.  The novel ATP-sensitive potassium channel opener iptakalim prevents insulin resistance associated with hypertension via restoring endothelial function.

Authors:  Yu Wang; Fu-hu Zeng; Chao-liang Long; Zhi-yuan Pan; Wen-yu Cui; Ru-huan Wang; Guo-shu Liu; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2011-11-07       Impact factor: 6.150

Review 4.  H2S- and NO-Signaling Pathways in Alzheimer's Amyloid Vasculopathy: Synergism or Antagonism?

Authors:  Alla B Salmina; Yulia K Komleva; István A Szijártó; Yana V Gorina; Olga L Lopatina; Galina E Gertsog; Milos R Filipovic; Maik Gollasch
Journal:  Front Physiol       Date:  2015-12-11       Impact factor: 4.566

5.  Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy.

Authors:  Hong-Min Zhou; Ming-Li Zhong; Yan-Fang Zhang; Wen-Yu Cui; Chao-Liang Long; Hai Wang
Journal:  Int J Mol Med       Date:  2014-09-12       Impact factor: 4.101

6.  Effects of pinacidil on changes to the microenvironment around the incision site, of a skin/muscle incision and retraction, in a rat model of postoperative pain.

Authors:  Su Cao; Yinbin Qin; Junjie Chen; Shiren Shen
Journal:  Mol Med Rep       Date:  2015-03-10       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.